Last reviewed · How we verify
Measles, Mumps, and Rubella Virus Vaccine Live
Measles, Mumps, and Rubella Virus Vaccine Live is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company. It is currently FDA-approved. Also known as: MMR vaccine, M-M-R ®II, M-M-R®II, V205C.
At a glance
| Generic name | Measles, Mumps, and Rubella Virus Vaccine Live |
|---|---|
| Also known as | MMR vaccine, M-M-R ®II, M-M-R®II, V205C |
| Sponsor | Sanofi Pasteur, a Sanofi Company |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Live Vaccines and Innate Immune Training in COPD. (PHASE4)
- A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population (PHASE3)
- Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers (PHASE3)
- Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa (PHASE3)
- the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines
- Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months (PHASE3)
- Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients (PHASE4)
- Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Measles, Mumps, and Rubella Virus Vaccine Live CI brief — competitive landscape report
- Measles, Mumps, and Rubella Virus Vaccine Live updates RSS · CI watch RSS
- Sanofi Pasteur, a Sanofi Company portfolio CI
Frequently asked questions about Measles, Mumps, and Rubella Virus Vaccine Live
What is Measles, Mumps, and Rubella Virus Vaccine Live?
Measles, Mumps, and Rubella Virus Vaccine Live is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company.
Who makes Measles, Mumps, and Rubella Virus Vaccine Live?
Measles, Mumps, and Rubella Virus Vaccine Live is developed and marketed by Sanofi Pasteur, a Sanofi Company (see full Sanofi Pasteur, a Sanofi Company pipeline at /company/sanofi).
Is Measles, Mumps, and Rubella Virus Vaccine Live also known as anything else?
Measles, Mumps, and Rubella Virus Vaccine Live is also known as MMR vaccine, M-M-R ®II, M-M-R®II, V205C.
What development phase is Measles, Mumps, and Rubella Virus Vaccine Live in?
Measles, Mumps, and Rubella Virus Vaccine Live is FDA-approved (marketed).
Related
- Manufacturer: Sanofi Pasteur, a Sanofi Company — full pipeline
- Also known as: MMR vaccine, M-M-R ®II, M-M-R®II, V205C
- Compare: Measles, Mumps, and Rubella Virus Vaccine Live vs similar drugs
- Pricing: Measles, Mumps, and Rubella Virus Vaccine Live cost, discount & access